Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction

Chemico-biological Interactions
Chin-Ju J HsiaoUrs A Boelsterli

Abstract

Trovafloxacin (TVX) is a fluoroquinolone antibiotic whose therapeutic use was severely restricted due to an unacceptable risk of idiosyncratic liver injury. Oxidative stress and mitochondrial injury have been implicated in fluoroquinolone toxicity, but the mechanisms underlying liver injury are poorly understood. Because TVX-induced hepatotoxicity cannot be modeled in normal healthy rodents, we asked whether an underlying genetic defect (heterozygous deficiency in mitochondrial superoxide dismutase, Sod2) might aggravate TVX-induced mitochondrial adverse effects. Wild-type and Sod2(+/-) mice were treated with vehicle or alatrofloxacin (the prodrug of TVX, 33mg/kg/day, ip) for 28 days. We found that hepatic protein carbonyls were increased by 2.5-fold and hepatic mitochondrial aconitase activity was decreased by 20% in mutant, but not wild-type mice. Because aconitase is a major target of peroxynitrite, we determined the extent of nitrotyrosine residues in hepatic mitochondrial proteins. Trovafloxacin significantly increased nitrotyrosine in Sod2(+/-) mice only. Using the NO-selective probe DAF-2, we found that TVX increased the production of mitochondrial NO in immortalized human hepatocytes. Similarly, mitochondrial Ca(2+) was...Continue Reading

References

Apr 30, 1991·Biochemical and Biophysical Research Communications·J H Lin, F J Castora
Jul 31, 1985·Biochemical and Biophysical Research Communications·F J CastoraD Kunes
Feb 1, 1993·Journal of Cellular Biochemistry·J W LawrenceT C Rowe
Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·K E Brighty, T D Gootz
Jan 15, 1998·FEBS Letters·P Ghafourifar, C Richter
Mar 5, 1999·Science·D C Wallace
Aug 17, 2000·Clinical Therapeutics·J Bertino, D Fish
Oct 2, 2003·European Journal of Biochemistry·Robert L LowDavid B Friedman
Nov 11, 2003·Free Radical Biology & Medicine·Zsombor LaczaDavid W Busija
Dec 25, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael J LiguoriJeffrey F Waring
Jun 1, 2005·Neuroscience Letters·Tiziana PersichiniMarco Colasanti
Dec 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Celine PerierMiquel Vila
Jan 31, 2006·Free Radical Biology & Medicine·Michie M K OngUrs A Boelsterli
Dec 8, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Michie M K OngUrs A Boelsterli
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Feb 6, 2007·Toxicology and Applied Pharmacology·Urs A Boelsterli, Priscilla L K Lim
Mar 23, 2007·Mitochondrion·Ali-Reza Moslemi, Niklas Darin
Jun 26, 2007·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Priscilla L K LimUrs A Boelsterli
Aug 22, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Patrick J ShawRobert A Roth
Oct 19, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shannon Reagan-ShawNihal Ahmad
Oct 31, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael J LiguoriJeffrey F Waring
Mar 5, 2008·The Journal of Biological Chemistry·Ivan GusarovEvgeny Nudler
Sep 3, 2008·Drug Discovery Today·Urs A Boelsterli, Chin-Ju J Hsiao
Nov 4, 2008·Biochemistry. Biokhimii︠a︡·L V Matasova, T N Popova
Nov 18, 2008·Biochimie·Chin-ju J Hsiao, Susan R Stapleton
Dec 9, 2008·The Biochemical Journal·Michael P Murphy
Apr 18, 2009·The Journal of Biological Chemistry·Priya VenkatakrishnanR Timothy Miller
Jun 16, 2009·Free Radical Biology & Medicine·Hao HongWeibo Cai
Jul 30, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Patrick J ShawRobert A Roth
Nov 10, 2009·Free Radical Biology & Medicine·Christiana W DavisMuniswamy Madesh
Jan 23, 2010·Free Radical Biology & Medicine·Brian P DrankaVictor M Darley-Usmar

❮ Previous
Next ❯

Citations

Jun 27, 2012·Chemical Research in Toxicology·Jacek ZielonkaBalaraman Kalyanaraman
Apr 23, 2011·Expert Opinion on Drug Metabolism & Toxicology·Jonathan G Stine, James H Lewis
Jul 16, 2014·Expert Opinion on Drug Metabolism & Toxicology·Yvonne Will, James Dykens
Oct 9, 2013·Clinics in Liver Disease·Jonathan G Stine, James H Lewis
Jul 6, 2011·Critical Reviews in Toxicology·Robert A Roth, Patricia E Ganey
Dec 4, 2015·Environmental Toxicology and Chemistry·Dana ZivnaZdenka Svobodova
Oct 24, 2013·Blood Reviews·Sophie Waldvogel-AbramovskiJean-Daniel Tissot
Oct 19, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Daphna LaifenfeldMichael Lawton
Jul 7, 2017·Medicinal Research Reviews·Matilde E LleonartAlex Lyakhovich
Apr 28, 2019·International Journal of Molecular Sciences·Steffi GoffartJaakko L O Pohjoismäki
Nov 18, 2017·Oxidative Medicine and Cellular Longevity·Krzysztof MichalakBogusław Sobolewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.